Report Detail
Global Heparin Market Insights, Forecast to 2025
- RnM2946162 |
- 14 February, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Other
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine
Heparin API is an anticoagulant (blood thinner) that prevents the formation of blood clots. With the accelerated pace of life and increasing aging population, global morbidity and mortality of cardiovascular and cerebrovascular disease are increased year by year. Heparin API is an efficient solution to those diseases.
Raw materials of Heparin API are mainly porcine intestine, bovine lung and bovine intestine, etc. China pig slaughter amount accounted for more than 50% of the world. It has most abundant raw material resources all over the world.
The classification of Heparin includes Heparin Sodium, Heparin Calcium and others, and the proportion of Heparin Sodium in 2016 is about 88%, and the proportion is in decreasing trend from 2012 to 2016.
Heparin is widely used UFH and LMWH. The most proportion of Heparin is used in LMWH, and the proportion in 2016 is 88.9%
Europe is the largest consumption place, with a consumption market share nearly 40% in 2016. Following Europe, United Stated is the second largest consumption place with the consumption market share of 36%.
Market competition is not intense. Hepalink, Bioibérica, Changshan Pharm, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.
Global Heparin market size will increase to 1290 Million US$ by 2025, from 990 Million US$ in 2018, at a CAGR of 3.4% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Heparin.
This report researches the worldwide Heparin market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Heparin breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The following manufacturers are covered in this report:
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma Limited
Deebio
Heparin Breakdown Data by Type
Heparin Sodium
Heparin Calcium
Other
Heparin Breakdown Data by Application
UFH
LMWH
Heparin Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Heparin Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Heparin capacity, production, value, consumption, status and forecast;
To focus on the key Heparin manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Heparin :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
Global Heparin Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications
1 Study Coverage
- 1.1 Heparin Product
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Heparin Market Size Growth Rate by Type
- 1.4.2 Heparin Sodium
- 1.4.3 Heparin Calcium
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Heparin Market Size Growth Rate by Application
- 1.5.2 UFH
- 1.5.3 LMWH
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Heparin Production
- 2.1.1 Global Heparin Revenue 2014-2025
- 2.1.2 Global Heparin Production 2014-2025
- 2.1.3 Global Heparin Capacity 2014-2025
- 2.1.4 Global Heparin Marketing Pricing and Trends
- 2.2 Heparin Growth Rate (CAGR) 2019-2025
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Key Heparin Manufacturers
- 2.4 Market Drivers, Trends and Issues
- 2.5 Macroscopic Indicator
- 2.5.1 GDP for Major Regions
- 2.5.2 Price of Raw Materials in Dollars: Evolution
3 Market Size by Manufacturers
- 3.1 Heparin Production by Manufacturers
- 3.1.1 Heparin Production by Manufacturers
- 3.1.2 Heparin Production Market Share by Manufacturers
- 3.2 Heparin Revenue by Manufacturers
- 3.2.1 Heparin Revenue by Manufacturers (2014-2019)
- 3.2.2 Heparin Revenue Share by Manufacturers (2014-2019)
- 3.3 Heparin Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Heparin Production by Regions
- 4.1 Global Heparin Production by Regions
- 4.1.1 Global Heparin Production Market Share by Regions
- 4.1.2 Global Heparin Revenue Market Share by Regions
- 4.2 United States
- 4.2.1 United States Heparin Production
- 4.2.2 United States Heparin Revenue
- 4.2.3 Key Players in United States
- 4.2.4 United States Heparin Import & Export
- 4.3 Europe
- 4.3.1 Europe Heparin Production
- 4.3.2 Europe Heparin Revenue
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Heparin Import & Export
- 4.4 China
- 4.4.1 China Heparin Production
- 4.4.2 China Heparin Revenue
- 4.4.3 Key Players in China
- 4.4.4 China Heparin Import & Export
- 4.5 Japan
- 4.5.1 Japan Heparin Production
- 4.5.2 Japan Heparin Revenue
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Heparin Import & Export
- 4.6 Other Regions
- 4.6.1 South Korea
- 4.6.2 India
- 4.6.3 Southeast Asia
5 Heparin Consumption by Regions
- 5.1 Global Heparin Consumption by Regions
- 5.1.1 Global Heparin Consumption by Regions
- 5.1.2 Global Heparin Consumption Market Share by Regions
- 5.2 North America
- 5.2.1 North America Heparin Consumption by Application
- 5.2.2 North America Heparin Consumption by Countries
- 5.2.3 United States
- 5.2.4 Canada
- 5.2.5 Mexico
- 5.3 Europe
- 5.3.1 Europe Heparin Consumption by Application
- 5.3.2 Europe Heparin Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 UK
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Heparin Consumption by Application
- 5.4.2 Asia Pacific Heparin Consumption by Countries
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Indonesia
- 5.4.9 Thailand
- 5.4.10 Malaysia
- 5.4.11 Philippines
- 5.4.12 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Heparin Consumption by Application
- 5.5.2 Central & South America Heparin Consumption by Countries
- 5.5.3 Brazil
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Heparin Consumption by Application
- 5.6.2 Middle East and Africa Heparin Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 GCC Countries
- 5.6.5 Egypt
- 5.6.6 South Africa
6 Market Size by Type
- 6.1 Global Heparin Breakdown Dada by Type
- 6.2 Global Heparin Revenue by Type
- 6.3 Heparin Price by Type
7 Market Size by Application
- 7.1 Overview
- 7.2 Global Heparin Breakdown Dada by Application
- 7.2.1 Global Heparin Consumption by Application
- 7.2.2 Global Heparin Consumption Market Share by Application (2014-2019)
8 Manufacturers Profiles
- 8.1 Hepalink
- 8.1.1 Hepalink Company Details
- 8.1.2 Company Description
- 8.1.3 Capacity, Production and Value of Heparin
- 8.1.4 Heparin Product Description
- 8.1.5 SWOT Analysis
- 8.2 Changshan Pharm
- 8.2.1 Changshan Pharm Company Details
- 8.2.2 Company Description
- 8.2.3 Capacity, Production and Value of Heparin
- 8.2.4 Heparin Product Description
- 8.2.5 SWOT Analysis
- 8.3 Qianhong Bio-pharma
- 8.3.1 Qianhong Bio-pharma Company Details
- 8.3.2 Company Description
- 8.3.3 Capacity, Production and Value of Heparin
- 8.3.4 Heparin Product Description
- 8.3.5 SWOT Analysis
- 8.4 Opocrin
- 8.4.1 Opocrin Company Details
- 8.4.2 Company Description
- 8.4.3 Capacity, Production and Value of Heparin
- 8.4.4 Heparin Product Description
- 8.4.5 SWOT Analysis
- 8.5 Pfizer
- 8.5.1 Pfizer Company Details
- 8.5.2 Company Description
- 8.5.3 Capacity, Production and Value of Heparin
- 8.5.4 Heparin Product Description
- 8.5.5 SWOT Analysis
- 8.6 Aspen Oss
- 8.6.1 Aspen Oss Company Details
- 8.6.2 Company Description
- 8.6.3 Capacity, Production and Value of Heparin
- 8.6.4 Heparin Product Description
- 8.6.5 SWOT Analysis
- 8.7 King-friend Biochemical Pharmaceutical
- 8.7.1 King-friend Biochemical Pharmaceutical Company Details
- 8.7.2 Company Description
- 8.7.3 Capacity, Production and Value of Heparin
- 8.7.4 Heparin Product Description
- 8.7.5 SWOT Analysis
- 8.8 Bioibérica
- 8.8.1 Bioibérica Company Details
- 8.8.2 Company Description
- 8.8.3 Capacity, Production and Value of Heparin
- 8.8.4 Heparin Product Description
- 8.8.5 SWOT Analysis
- 8.9 Dongcheng Biochemicals
- 8.9.1 Dongcheng Biochemicals Company Details
- 8.9.2 Company Description
- 8.9.3 Capacity, Production and Value of Heparin
- 8.9.4 Heparin Product Description
- 8.9.5 SWOT Analysis
- 8.10 Jiulong Biochemicals
- 8.10.1 Jiulong Biochemicals Company Details
- 8.10.2 Company Description
- 8.10.3 Capacity, Production and Value of Heparin
- 8.10.4 Heparin Product Description
- 8.10.5 SWOT Analysis
- 8.11 Tiandong
- 8.12 Xinbai
- 8.13 Yino Pharma Limited
- 8.14 Deebio
9 Production Forecasts
- 9.1 Heparin Production and Revenue Forecast
- 9.1.1 Global Heparin Production Forecast 2019-2025
- 9.1.2 Global Heparin Revenue Forecast 2019-2025
- 9.2 Heparin Production and Revenue Forecast by Regions
- 9.2.1 Global Heparin Revenue Forecast by Regions
- 9.2.2 Global Heparin Production Forecast by Regions
- 9.3 Heparin Key Producers Forecast
- 9.3.1 United States
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
- 9.4 Forecast by Type
- 9.4.1 Global Heparin Production Forecast by Type
- 9.4.2 Global Heparin Revenue Forecast by Type
10 Consumption Forecast
- 10.1 Consumption Forecast by Application
- 10.2 Heparin Consumption Forecast by Regions
- 10.3 North America Market Consumption Forecast
- 10.3.1 North America Heparin Consumption Forecast by Countries 2019-2025
- 10.3.2 United States
- 10.3.3 Canada
- 10.3.4 Mexico
- 10.4 Europe Market Consumption Forecast
- 10.4.1 Europe Heparin Consumption Forecast by Countries 2019-2025
- 10.4.2 Germany
- 10.4.3 France
- 10.4.4 UK
- 10.4.5 Italy
- 10.4.6 Russia
- 10.5 Asia Pacific Market Consumption Forecast
- 10.5.1 Asia Pacific Heparin Consumption Forecast by Countries 2019-2025
- 10.5.2 China
- 10.5.3 Japan
- 10.5.4 Korea
- 10.5.5 India
- 10.5.6 Australia
- 10.5.7 Indonesia
- 10.5.8 Thailand
- 10.5.9 Malaysia
- 10.5.10 Philippines
- 10.5.11 Vietnam
- 10.6 Central & South America Market Consumption Forecast
- 10.6.1 Central & South America Heparin Consumption Forecast by Country 2019-2025
- 10.6.2 Brazil
- 10.7 Middle East and Africa Market Consumption Forecast
- 10.7.1 Middle East and Africa Heparin Consumption Forecast by Countries 2019-2025
- 10.7.2 Middle East and Africa
- 10.7.3 Turkey
- 10.7.4 GCC Countries
- 10.7.5 Egypt
- 10.7.6 South Africa
11 Upstream, Industry Chain and Downstream Customers Analysis
- 11.1 Analysis of Heparin Upstream Market
- 11.1.1 Heparin Key Raw Material
- 11.1.2 Typical Suppliers of Key Heparin Raw Material
- 11.1.3 Heparin Raw Material Market Concentration Rate
- 11.2 Heparin Industry Chain Analysis
- 11.3 Marketing & Distribution
- 11.4 Heparin Distributors
- 11.5 Heparin Customers
12 Opportunities & Challenges, Threat and Affecting Factors
- 12.1 Market Opportunities
- 12.2 Market Challenges
- 12.3 Porter's Five Forces Analysis
13 Key Findings
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Heparin . Industry analysis & Market Report on Heparin is a syndicated market report, published as Global Heparin Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Heparin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
